InChI=1S/C22H37NO3/c1-2-3-4-5-6-7-8-9-12-15-20-21(26-20)16-13-10-11-14-17-22(25)23-18-19-24/h6-7,9-10,12-13,20-21,24H,2-5,8,11,14-19H2,1H3,(H,23,25)/b7-6-,12-9-,13-10- |
BXHPMUQFGGSDAK-TYAUOURKSA-N |
C(CCC)C/C=C\C/C=C\CC1C(C/C=C\CCCC(NCCO)=O)O1 |
|
Bronsted base
A molecular entity capable of accepting a hydron from a donor (Bronsted acid).
(via organic amino compound )
|
|
human xenobiotic metabolite
Any human metabolite produced by metabolism of a xenobiotic compound in humans.
metabolite
Any intermediate or product resulting from metabolism. The term 'metabolite' subsumes the classes commonly known as primary and secondary metabolites.
(via endocannabinoid )
cannabinoid receptor agonist
An agonist that binds to and activates cannabinoid receptors.
(via cannabinoid )
|
|
View more via ChEBI Ontology
Outgoing
|
N-[(5Z,11Z,14Z)-8,9-epoxyicosatrienoyl]ethanolamine
(CHEBI:136989)
has functional parent
8,9-EET
(CHEBI:34490)
N-[(5Z,11Z,14Z)-8,9-epoxyicosatrienoyl]ethanolamine
(CHEBI:136989)
has functional parent
anandamide
(CHEBI:2700)
N-[(5Z,11Z,14Z)-8,9-epoxyicosatrienoyl]ethanolamine
(CHEBI:136989)
has role
human xenobiotic metabolite
(CHEBI:76967)
N-[(5Z,11Z,14Z)-8,9-epoxyicosatrienoyl]ethanolamine
(CHEBI:136989)
is a
N-(long-chain-acyl)ethanolamine
(CHEBI:15897)
N-[(5Z,11Z,14Z)-8,9-epoxyicosatrienoyl]ethanolamine
(CHEBI:136989)
is a
N-(polyunsaturated fatty acyl)ethanolamine
(CHEBI:85281)
N-[(5Z,11Z,14Z)-8,9-epoxyicosatrienoyl]ethanolamine
(CHEBI:136989)
is a
endocannabinoid
(CHEBI:67197)
N-[(5Z,11Z,14Z)-8,9-epoxyicosatrienoyl]ethanolamine
(CHEBI:136989)
is a
epoxide
(CHEBI:32955)
N-[(5Z,11Z,14Z)-8,9-epoxyicosatrienoyl]ethanolamine
(CHEBI:136989)
is a
oxidized N-(fatty acyl)-ethanolamine
(CHEBI:167118)
|
|
(5Z)-N-(2-hydroxyethyl)-7-{3-[(2Z,5Z)-undeca-2,5-dien-1-yl]oxiran-2-yl}hept-5-enamide
|
8(9)-EET-EA
|
SUBMITTER
|
8(9)-EpETrE-EA
|
LIPID MAPS
|
8,9-EET-EA
|
ChEBI
|
N-(8,9-epoxy-5Z,11Z,14Z-eicosatrienoyl)-ethanolamine
|
UniProt
|
N-(8,9-epoxy-5Z,11Z,14Z-icosatrienoyl)ethanolamine
|
ChEBI
|
11069012
|
Reaxys Registry Number
|
Reaxys
|
20702771
|
PubMed citation
|
SUBMITTER
|
21689782
|
PubMed citation
|
Europe PMC
|
27000802
|
PubMed citation
|
Europe PMC
|
|